Clinical Trial Update: Evaluation of Safety, Tolerability, and Efficacy of INZ-701 in Adults With ABCC6 Deficiency Causing PXE [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports Phase 1/2 results for INZ-701 in adults with ABCC6 deficiency–associated pseudoxanthoma elasticum, assessing safety, tolerabi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Generalized Arterial Calcification of Infancy
• Pseudoxanthoma Elasticum

Drugs mentioned

• INZ-701

Snippet

Sponsor: Inozyme Pharma | Conditions: ATP-Binding Cassette Subfamily C Member 6 Deficiency, Pseudoxanthoma Elasticum | Phase 1, Phase 2 | Status: COMPLETED